Work

Hypermethylation of theBreast Cancer–Associated Gene 1Promoter Does Not Predict Cytologic Atypia or Correlate with Surrogate End Points of Breast Cancer Risk

Year: 2007

Type: article

Study design: Observational Study

Source: Cancer Epidemiology Biomarkers & Prevention

DOI: 10.1158/1055-9965.epi-06-0598

Authors: Gregory R. Bean, Catherine Ibarra Drendall, Vanessa K. Goldenberg, Joseph C. Baker, Michelle M. Troch, Carolyn Paisie, Lee G. Wilke, Lisa Yee, Paul K. Marcom, Bruce F. Kimler, Carol J. Fabian, Carola M. Zalles, Gloria Broadwater, Victoria Scott, Victoria L. Seewaldt

Institutions: Duke University, Duke Medical Center, The Ohio State University Wexner Medical Center, The Ohio State University, University of Kansas Medical Center, Yale University

Language: English

Topic: Epigenetics and DNA Methylation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G1441631707, G26232550, G324826314, SPORE IN BREAST CANCER, ECM-Mediated Apoptosis in p53 (-) HMECs, p53 loss in HMECs: a model of breast cancer prevention, G876364176, Cancer Center Support Grant (CCSG)

OpenAlex ID: W2019243315

FWCI: 1.316

Cites: 54

Cited by: 24

Related to: 10